Epocrates Overview

  • Founded
  • 1998
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 320
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $293M
Latest Deal Amount

Epocrates General Information

Description

Developer of clinical information and decision support tools for health-care professionals. The company offers an integrated diagnostic suite, a drug reference guide, a guide to ICD-9 and CPT codes, a guide to various medical terms, and a free on-the-go learning center. It also provides market research, formulary hosting and medical education services.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Decision/Risk Analysis
Parent Company
Primary Office
  • 311 Arsenal Street
  • Watertown, MA 02472
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Epocrates Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 07-Jan-2013 $293M 00000 00000 Completed Generating Revenue
6. IPO 02-Feb-2011 000.00 00000 00000 Completed Generating Revenue
5. IPO 12-Dec-2008 0000 Cancelled Product Development
4. Later Stage VC 03-Jan-2008 0000 000.00 Completed Product Development
3. Later Stage VC (Series C) 02-Jul-2002 00.000 000.00 000.00 Completed Product Development
2. Early Stage VC (Series B) 17-Aug-2000 $35.5M $39.7M 00000 Completed Product Development
1. Early Stage VC (Series A) 01-Sep-1999 $4.2M $4.2M 000.00 Completed Product Development
To view Epocrates’s complete valuation and funding history, request access »

Epocrates Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A 5,050,000 $0.001000 8% $1 $1 1x $1 19.04%
To view Epocrates’s complete cap table history, request access »

Epocrates Patents

Epocrates Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20070226260-A1 System and method for linking and managing audio, video, image, and text data on an ipod Abandoned 09-Feb-2006 000000000 00
US-6944859-B2 System and method for automatically installing data on a handheld computer Active 30-Jan-2003 00000000 00
US-20040154014-A1 System and method for automatically installing data on a handheld computer Granted 30-Jan-2003 00000000 00
CA-2513801-A1 System and method for automatically installing data on a handheld computer Abandoned 30-Jan-2003 00000000
JP-2006517046-A System and method for automatic data installation in handheld computers Granted 30-Jan-2003 G06F8/61 0
To view Epocrates’s complete patent history, request access »

Epocrates Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Epocrates Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bay City Capital Venture Capital Minority 000 0000 000000 0
Draper Fisher Jurvetson Management Venture Capital Minority 000 0000 000000 0
Goldman Sachs Merchant Banking Division Merchant Banking Firm Minority 000 0000 000000 0
Industry Ventures Venture Capital Minority 000 0000 000000 0
InterWest Health Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

Epocrates Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 19-Nov-2010 0000000000 000.00 Educational Software 00000000
To view Epocrates’s complete acquisitions history, request access »